Pharmacological inhibiting STAT5 for the treatment of FLT3-ITD-positive acute myeloid leukemia with triciribine phosphate monohydrate

被引:2
|
作者
Wu, Hong [1 ,2 ]
Ge, Juan [1 ,3 ]
Zou, Fengming [1 ,2 ]
Jiang, Zongru [1 ]
Wang, Beilei [1 ,2 ]
Yuan, Xinyu [1 ,3 ]
Long, Kaili [1 ,3 ]
Liu, Jing [1 ,2 ,3 ,4 ]
Wang, Wenchao [1 ,2 ,3 ,4 ]
Liu, Qingsong [1 ,2 ,3 ,4 ]
机构
[1] Chinese Acad Sci, Inst Hlth & Med Technol, Hefei Inst Phys Sci, Anhui Prov Key Lab Med Phys & Technol, Hefei, Anhui, Peoples R China
[2] Chinese Acad Sci, Hefei Canc Hosp, Hefei, Anhui, Peoples R China
[3] Univ Sci & Technol China, Hefei, Anhui, Peoples R China
[4] Chinese Acad Sci, Inst Hlth & Med Technol, Hefei Inst Phys Sci, Hefei 230031, Anhui, Peoples R China
来源
MEDCOMM | 2023年 / 4卷 / 04期
基金
中国国家自然科学基金;
关键词
D O I
10.1002/mco2.294
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Characteristics and Outcome of FLT3-ITD-Positive Acute Myeloid Leukemia
    Li, Hong
    Wang, Lingling
    Mu, Jiao
    CLINICAL LABORATORY, 2024, 70 (11) : 2125 - 2131
  • [2] Abrogating Treatment Resistance By Mir-451 in FLT3-ITD-Positive Acute Myeloid Leukemia
    Krakowsky, Rosanna H. E.
    Wurm, Alexander Arthur
    Gerloff, Dennis
    Katzerke, Christiane
    Hartmann, Jens-Uwe
    Brauer-Hartmann, Daniela
    Wilke, Franziska
    Thiede, Christian
    Mueller-Tidow, Carsten
    Niederwieser, Dietger
    Behre, Gerhard
    BLOOD, 2017, 130
  • [3] miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
    Rosanna H. E. Krakowsky
    Alexander A. Wurm
    Dennis Gerloff
    Christiane Katzerke
    Daniela Bräuer-Hartmann
    Jens-Uwe Hartmann
    Franziska Wilke
    Christian Thiede
    Carsten Müller-Tidow
    Dietger Niederwieser
    Gerhard Behre
    Blood Cancer Journal, 8
  • [4] Successful Treatment with Gilteritinib for FLT3-ITD-positive Refractory Acute Myeloid Leukemia in a Pediatric Patient
    Fujita, Naoto
    Tamura, Yumi
    Shiraishi, Yasutaka
    Tsuboi, Ayana
    Ohno, Norioki
    Miki, Mizuka
    Chijimatsu, Ikue
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S11 - S11
  • [5] miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
    Krakowsky, Rosanna H. E.
    Wurm, Alexander A.
    Gerloff, Dennis
    Katzerke, Christiane
    Braeuer-Hartmann, Daniela
    Hartmann, Jens-Uwe
    Wilke, Franziska
    Thiede, Christian
    Mueller-Tidow, Carsten
    Niederwieser, Dietger
    Behre, Gerhard
    BLOOD CANCER JOURNAL, 2018, 8
  • [6] Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia
    Kakiuchi, Seiji
    Yakushijin, Kimikazu
    Sakai, Rina
    Kawaguchi, Koji
    Higashime, Ako
    Kurata, Keiji
    Ichikawa, Hiroya
    Nagao, Shigeki
    Rikitake, Junpei
    Kiyota, Naomi
    Matsuoka, Hiroshi
    Minami, Hironobu
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (08) : 2010 - 2015
  • [7] Childhood Noonan Syndrome with FLT3-ITD-Positive Acute Myeloid Leukemia - A Case Report
    Sarashina, T.
    Goto, H.
    Miyagawa, N.
    Yokosuka, T.
    Fukuda, K.
    Iwasaki, F.
    Hamanoue, S.
    Shiomi, M.
    Goto, S.
    Azuma, H.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S442 - S443
  • [8] FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia
    Chougule, Rohit A.
    Kazi, Julhash U.
    Ronnstrand, Lars
    ONCOTARGET, 2016, 7 (09) : 9964 - 9974
  • [9] A novel prognostic scoring model for newly diagnosed FLT3-ITD-positive acute myeloid leukemia
    Zhang, Yi
    Zhao, Bi-De
    Wang, Cheng-Cheng
    Wang, Yun-Gui
    Wang, Hua-Feng
    Wang, Jing-Han
    Liu, Li-Xia
    Lou, Feng
    Cao, Shan-Bo
    Hu, Xiao-Xia
    Huang, Ai-Jie
    Yang, Jian-Min
    Meng, Hai-Tao
    Yu, Wen-Juan
    Tong, Hong-Yan
    Wang, Jian-Min
    Jin, Jie
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (12): : 4527 - +
  • [10] Erythroid differentiation of myeloblast induced by gilteritinib in relapsed FLT3-ITD-positive acute myeloid leukemia
    Yun, Hyun Don
    Nathan, Sunita
    Larson, Melissa
    Hussain, Mohammad J.
    Katz, Deborah A.
    Varma, Ankur
    Miller, Ira
    Ustun, Celalettin
    BLOOD ADVANCES, 2019, 3 (22) : 3709 - 3712